India · Delayed Price · Currency is INR Ipca Laboratories Statistics
Total Valuation
NSE:IPCALAB has a market cap or net worth of INR 453.60 billion. The enterprise value is 464.33 billion.
| Market Cap | 453.60B |
| Enterprise Value | 464.33B |
Important Dates
The next estimated earnings date is Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | Aug 7, 2026 |
Share Statistics
NSE:IPCALAB has 253.70 million shares outstanding. The number of shares has decreased by -0.00% in one year.
| Current Share Class | 253.70M |
| Shares Outstanding | 253.70M |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | -6.00% |
| Owned by Insiders (%) | 7.13% |
| Owned by Institutions (%) | 47.36% |
| Float | 139.31M |
Valuation Ratios
The trailing PE ratio is 39.75 and the forward PE ratio is 32.37. NSE:IPCALAB's PEG ratio is 1.61.
| PE Ratio | 39.75 |
| Forward PE | 32.37 |
| PS Ratio | 4.70 |
| PB Ratio | 4.76 |
| P/TBV Ratio | 5.77 |
| P/FCF Ratio | 93.33 |
| P/OCF Ratio | 39.72 |
| PEG Ratio | 1.61 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.90, with an EV/FCF ratio of 95.54.
| EV / Earnings | 40.69 |
| EV / Sales | 4.81 |
| EV / EBITDA | 22.90 |
| EV / EBIT | 28.71 |
| EV / FCF | 95.54 |
Financial Position
The company has a current ratio of 2.76, with a Debt / Equity ratio of 0.08.
| Current Ratio | 2.76 |
| Quick Ratio | 1.48 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 0.40 |
| Debt / FCF | 1.66 |
| Interest Coverage | 21.46 |
Financial Efficiency
Return on equity (ROE) is 13.22% and return on invested capital (ROIC) is 13.10%.
| Return on Equity (ROE) | 13.22% |
| Return on Assets (ROA) | 8.42% |
| Return on Invested Capital (ROIC) | 13.10% |
| Return on Capital Employed (ROCE) | 16.15% |
| Weighted Average Cost of Capital (WACC) | 4.57% |
| Revenue Per Employee | 5.61M |
| Profits Per Employee | 663,056 |
| Employee Count | 16,778 |
| Asset Turnover | 0.80 |
| Inventory Turnover | 1.20 |
Taxes
In the past 12 months, NSE:IPCALAB has paid 3.81 billion in taxes.
| Income Tax | 3.81B |
| Effective Tax Rate | 24.36% |
Stock Price Statistics
The stock price has increased by +22.30% in the last 52 weeks. The beta is 0.05, so NSE:IPCALAB's price volatility has been lower than the market average.
| Beta (5Y) | 0.05 |
| 52-Week Price Change | +22.30% |
| 50-Day Moving Average | 1,612.18 |
| 200-Day Moving Average | 1,479.00 |
| Relative Strength Index (RSI) | 71.39 |
| Average Volume (20 Days) | 226,456 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:IPCALAB had revenue of INR 96.47 billion and earned 11.41 billion in profits. Earnings per share was 44.98.
| Revenue | 96.47B |
| Gross Profit | 64.86B |
| Operating Income | 16.25B |
| Pretax Income | 15.65B |
| Net Income | 11.41B |
| EBITDA | 20.09B |
| EBIT | 16.25B |
| Earnings Per Share (EPS) | 44.98 |
Balance Sheet
The company has 11.96 billion in cash and 8.09 billion in debt, with a net cash position of 3.87 billion or 15.25 per share.
| Cash & Cash Equivalents | 11.96B |
| Total Debt | 8.09B |
| Net Cash | 3.87B |
| Net Cash Per Share | 15.25 |
| Equity (Book Value) | 95.24B |
| Book Value Per Share | 317.84 |
| Working Capital | 40.70B |
Cash Flow
In the last 12 months, operating cash flow was 11.42 billion and capital expenditures -6.56 billion, giving a free cash flow of 4.86 billion.
| Operating Cash Flow | 11.42B |
| Capital Expenditures | -6.56B |
| Depreciation & Amortization | 4.18B |
| Net Borrowing | -6.20B |
| Free Cash Flow | 4.86B |
| FCF Per Share | 19.16 |
Margins
Gross margin is 67.23%, with operating and profit margins of 16.85% and 11.83%.
| Gross Margin | 67.23% |
| Operating Margin | 16.85% |
| Pretax Margin | 16.22% |
| Profit Margin | 11.83% |
| EBITDA Margin | 20.83% |
| EBIT Margin | 16.85% |
| FCF Margin | 5.04% |
Dividends & Yields
This stock pays an annual dividend of 6.00, which amounts to a dividend yield of 0.34%.
| Dividend Per Share | 6.00 |
| Dividend Yield | 0.34% |
| Dividend Growth (YoY) | 50.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 4.59% |
| Buyback Yield | 0.00% |
| Shareholder Yield | 0.34% |
| Earnings Yield | 2.52% |
| FCF Yield | 1.07% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for NSE:IPCALAB is 1,733.50, which is -3.39% lower than the current price. The consensus rating is "Buy".
| Price Target | 1,733.50 |
| Price Target Difference | -3.39% |
| Analyst Consensus | Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (3Y) | 11.30% |
| EPS Growth Forecast (3Y) | 18.16% |
Stock Splits
The last stock split was on January 10, 2022. It was a forward split with a ratio of 2.
| Last Split Date | Jan 10, 2022 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
NSE:IPCALAB has an Altman Z-Score of 10.08 and a Piotroski F-Score of 8.
| Altman Z-Score | 10.08 |
| Piotroski F-Score | 8 |